Karthikeyan Mythreye

20PUBLICATIONS
70CO-AUTHORS
Cancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 10, 2026
Aging increases ovarian cancer growth, metastasis, and immunosuppression that can be alleviated by inhibiting hedgehog signaling.

|Apr 16, 2026
RHOV Is a Detachment-Responsive Rho GTPase Necessary for Ovarian Cancer Peritoneal Metastasis.

|Aug 20, 2025
RHOV is a Detachment-Responsive Rho GTPase Necessary for Ovarian Cancer Peritoneal Metastasis.

Amal T Elhaw, Priscilla W Tang, Ya-Yun Cheng

|Jul 09, 2025
Loss of Predicted Cell Adhesion Molecule MPZL3 Promotes EMT in Ovarian Cancer.

Ya-Yun Cheng, Beth L Worley, Zaineb Javed

|Mar 28, 2025
Targeting Mediator Kinase Cyclin-Dependent Kinases 8/19 Potentiates Chemotherapeutic Responses, Reverses Tumor Growth, and Prolongs Survival from Ovarian Clear Cell Carcinoma.

Wade C Barton, Asha Kumari, Zachary T Mack

|Nov 28, 2024
Loss of the predicted cell adhesion molecule MPZL3 promotes EMT and chemoresistance in ovarian cancer.

Ya-Yun Cheng, Beth L Worley, Zaineb Javed

Pageof 4

Frequent Collaborators

9 joint publications

Nadine Hempel

7 joint publications

Shriya Kamlapurkar

6 joint publications

Ya-Yun Cheng

6 joint publications

Zaineb Javed